Objectives: Osteoporosis is a disease of bones that is thought to result from an imbalance between bone resorption and bone formation. Although osteoporosis itself has no symptoms, osteoporosis caused by osteoclasts leads to an increased risk of fracture. Here we examined the effects of cornus officinalis on receptor activator of nuclear factor-kappaB ligand (RANKL)-mediated osteoclast differentiation. Methods: We evaluated the effects of cornus officinalis on RANKL-induced osteoclast differentiation from bone marrow-derived macrophages (BMMs) and performed a cytotoxicity assay, reverse transcriptase-polymerase chain reaction (RT-PCR), and Western blot analysis. Results: Cornus officinalis significantly inhibits RANKL-mediated osteoclast differentiation in a dose-dependent manner, but without cytotoxicity against BMMs. The mRNA expression of tartrate-resistant acid phosphatase (TRAP), osteoclast-associated receptor (OSCAR), c-Fos, and nuclear factor of activated T cells cytoplasmic 1 (NFATc1) in BMMs treated with RANKL was considerably inhibited by cornus officinalis treatment. Also, cornus officinalis inhibits the protein expression of c-Fos and NFATc1. Cornus officinalis greatly inhibits RANKL-induced phosphorylation of p38 and c-JUN N-terminal kinase (JNK). Also, cornus officinalis significantly suppresses RANKL-induced degradation of I-κB. Conclusions: Taken together, our results suggest that cornus officinalis may be a useful the treatment of osteoporosis.
INTRODUCTION
Bone mass is maintained by a homeostatic balance between the activities of osteoclasts, which resorb bone, and those of osteoblasts, which make bone. The balance between both cells is under the control of various hormones kinase (MAPK) and nuclear factor-kappaB (NF-κB). [5, 6] Ultimately, RANKL leads to osteoclast differentiation by inducing transcription factors, including c-Fos and nuclear factor of activated T cells cytoplasmic 1 (NFATc1). [7] In particular, NFATc1 rescues osteoclast differentiation in cells lacking c-Fos and can induce osteoclast differentiation in the presence of RANKL. [8] Recently, many plant-derived natural products have been used in traditional medicine for the treatment of various diseases. We previously reported that several extracts derived from natural products, including papaya, deer antler, and drynariae rhizome, had inhibitory effects on osteoclast differentiation. [9] [10] [11] Cornus officinalis, a species of dogwood, was used as a food plant. In particular, the fruit of cornus officinalis was widely used for its chemotherapeutic benefits. Recently, cornuside, isolated from the fruit of cornus officinalis, suppressed inflammation by inhibiting TNF-alpha (α)-induced NF-κB p65 translocation to the nucleus. [12] Cornuside has also been reported to inhibit lipopolysaccharide-induced inflammation through inhibition of NF-κB activity. [13] Recently, an aqueous extract prepared from the fruit of a popular Chinese herb Cornus officinalis had strong anti-proliferative effect on estrogen receptor-positive breast cancer cells. [14] Taken together, it is possible that an extract obtained from
Cornus officinalis suppresses RANKL-induced osteoclast differentiation by inhibiting NF-κB activity. Thus, we examined the effects of Cornus officinalis on osteoclast differentiation.
MATERIALS AND METHODS

Reagents
An extract of cornus officinalis was from Plant Extract 
Osteoclast differentiation
Bone marrow cells (BMCs) were freshly isolated from the long bones of 5-week-old male ICR mice as described previously. [15] Briefly, BMCs were isolated from long bones by flushing with α-minimum essential medium Osteoclasts were stained with TRAP solution and counted as osteoclasts.
Cytotoxicity assay
BMMs were seeded at 1 × 10 
Western blotting
Cells were lysed in lysis buffer containing 50 mM Tris-Cl, 150 mM NaCl, 5 mM ethylenediaminetetraacetic acid (EDTA), 1% Triton X-100, 1 mM sodium fluoride, 1 mM sodium vanadate, 1% deoxycholate, and protease inhibitors. 
RNA isolation and reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was extracted from cultured cells using the 
Statistics
Statistical significance was analyzed by a Student's t test, and significant results (P < 0.1) are marked by asterisks.
RESULTS
Effects of cornus officinalis on osteoclast differentiation
To examine the effect of cornus officinalis on osteoclast differentiation, BMMs were cultured with M-CSF and RANKL in the presence or absence of cornus officinalis.
Osteoclasts were formed from BMM in the presence of M-CSF, RANKL, and dissolved in dimethyl sulfoxide (DMSO) as vehicle. However, cornus officinalis greatly inhibits the differentiation of BMMs, as evaluated by the number of TRAP-positive osteoclasts (Fig. 1A, 1B) . To exclude the possibility that cornus officinalis can cause cytotoxicity on BMMs during osteoclast differentiation, the cytotoxicity assay was performed. Cornus officinalis can no cytotoxic effects at the same doses which considerably inhibited osteoclast differentiation (Fig. 1C) .
Effects of cornus officinalis in osteoclast-specific gene expression
Next, we examined the inhibitory effect of cornus offi- 
Effects of cornus officinalis on RANKL-induced early signaling
It is well known that RANKL activates multiple intracellular signaling cascades that lead to osteoclast differentiation. [7] To examine the molecular mechanism of the inhibitory effects of cornus officinalis on osteoclast differentiation, we examined the effects of cornus officinalis on the early signaling pathways in BMMs treated with RANKL.
RANKL-induced phosphorylation of p38 and JNK was increased at 5 min after RANKL treatment, but both p38
and JNK phosphorylation was inhibited by cornus officinalis treatment. Also, RANKL induces degradation of I-κB within 5 min, but cornus officinalis suppresses I-κB degradation (Fig. 4) . These results suggest that the inhibition of early signaling pathways is, at least, involved in the cornus officinalis-induced inhibition of transcription factors and osteoclast differentiation.
DISCUSSION
In human, the function of bones is to mechanically Fig. 2 . Cornus officinalis inhibits osteoclast-specific gene expression. bone marrow-derived macrophages (BMMs) were treated with or without Cornus officinalis (100 μg/mL) and further stimulated with receptor activator of nuclear factor-kappaB ligand (RANKL; 100 n/mL) for the indicated time. cDNA was synthesized by using total RNA and reverse transcriptase-polymerase chain reaction (RT-PCR) was performed using cDNA. PCR products were separated by electrophoresis in an agarose gel and visualized with ethidium bromide staining. Similar results were obtained in three independent experiments. DMSO, dimethyl sulfoxide; TRAP, tartrate-resistant acid phosphatase; OSCAR, osteoclast-associated receptor; NFATc1, nuclear factor of activated T cells cytoplasmic 1, GAPDH, glyceraldehyde-3-phosphate dehydrogenase Fig. 3 . Cornus officinalis inhibits the expression of c-Fos and nuclear factor of activated T cells cytoplasmic 1 (NFATc1). Bone marrow-derived macrophages (BMMs) were pretreated with or without Cornus officinalis (100 μg/mL) and further stimulated with receptor activator of nuclear factor-kappaB ligand (RANKL; 100 n/mL) for the indicated time. The cells were lysed and proteins were revolved by 10% SDS-polyacrylamide gel electrophoresis (PAGE) and subjected to Western blot analysis. Similar results were obtained in three independent experiments. DMSO, dimethyl sulfoxide where it acts as a transcription factor. [22] In this study, I-κB was shown to undergo degradation within 5 min after treatment with RANKL. However, RANKL-induced I-κB degradation was greatly inhibited in the presence of cornus officinalis. Also, cornus officinalis significantly inhibited the phosphorylation of p38 and JNK induced by RANKL (Fig. 4 ). These results demonstrate that Cornus officinalis may inhibit osteoclast differentiation that may be involved in the inhibition of the signaling cascades NF-κB/c-Fos/ NFATc1.
CONCLUSION
Single compounds obtained from Cornus officinalis is known to inhibit inflammation by regulating NF-κB. In this study, we found that an extract derived from cornus officinalis inhibited RANKL-induced osteoclast differentiation without cytotoxicity. The expression of c-Fos and NFATc1, the master transcription factors of osteoclast differentiation, was inhibited by cornus officinalis treatment.
Cornus officinalis inhibited p38 and JNK phosphorylation and I-κB degradation in BMMs treated with RANKL.
